Arthrosi Therapeutics Secures $153 Million in Series E Financing to Advance Late-Stage Gout Treatment Read more
Algen Biotechnologies and AstraZeneca Partner to Accelerate Immunology Drug Discovery Using AI and CRISPR Read more
NanoPhoria Bioscience Secures €83.5 Million Series A to Advance Novel Heart Failure Therapy Read more
Oragenics Partners with Receptor.AI to Expand Neurological Drug Pipeline Using AI-Powered Discovery Read more
Affinia Therapeutics Secures $40 Million to Advance First-in-Class Gene Therapy for Rare Heart Disease Read more
Datroway Becomes First Therapy to Improve Survival Over Chemotherapy in Hard-to-Treat Triple-Negative Breast Cancer Read more
Chiesi Group and Arbor Biotechnologies Partner to Advance Gene Editing Therapies for Rare Liver Diseases Read more
FDA Lifts Clinical Hold on Neurizon Therapeutics’ ALS Drug NUZ-001, Clearing Path for Phase 2/3 Trial Read more
FDA Approves Roche’s Tecentriq and Lurbinectedin Combo as First Maintenance Therapy for Advanced Small Cell Lung Cancer Read more